Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pollard

Showing results (541-550 of 642) with videos related to

Pageof 65
Sort By:
The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.
Journal of Virology|September 2, 2011
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollersJulia M Shaw, Peter W Hunt, J William Critchfield, et al.
Frontiers in Molecular Neuroscience|October 11, 2016
"Soldier's Heart": A Genetic Basis for Elevated Cardiovascular Disease Risk Associated with Post-traumatic Stress DisorderHarvey B Pollard, Chittari Shivakumar, Joshua Starr, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 4, 2016
Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor ProgressionTimothy F Day, Rajshree R Mewani, Joshua Starr, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patientsRobin Wood, Keikawus Arasteh, Hans-Jürgen Stellbrink, et al.
Plos One|September 13, 2012
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384Todd Hulgan, Gregory K Robbins, Spyros A Kalams, et al.
Plos One|October 19, 2012
Identifying conservation successes, failures and future opportunities; assessing recovery potential of wild ungulates and tigers in Eastern CambodiaHannah J O'Kelly, Tom D Evans, Emma J Stokes, et al.
AIDS (London, England)|May 29, 2004
Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12Beverly E Sha, Michelle Onorato, John A Bartlett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3R B Pollard, D Peterson, D Hardy, et al.
AIDS (London, England)|November 2, 2005
Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individualsHaydar Kuekrek, Tobias Schlingmann, Hernan Valdez, et al.
Pageof 65

Showing results (541-550 of 642) with videos related to

Sort By:
Pageof 65
The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.
Journal of Virology|September 2, 2011
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollersJulia M Shaw, Peter W Hunt, J William Critchfield, et al.
Frontiers in Molecular Neuroscience|October 11, 2016
"Soldier's Heart": A Genetic Basis for Elevated Cardiovascular Disease Risk Associated with Post-traumatic Stress DisorderHarvey B Pollard, Chittari Shivakumar, Joshua Starr, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 4, 2016
Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor ProgressionTimothy F Day, Rajshree R Mewani, Joshua Starr, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patientsRobin Wood, Keikawus Arasteh, Hans-Jürgen Stellbrink, et al.
Plos One|September 13, 2012
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384Todd Hulgan, Gregory K Robbins, Spyros A Kalams, et al.
Plos One|October 19, 2012
Identifying conservation successes, failures and future opportunities; assessing recovery potential of wild ungulates and tigers in Eastern CambodiaHannah J O'Kelly, Tom D Evans, Emma J Stokes, et al.
AIDS (London, England)|May 29, 2004
Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12Beverly E Sha, Michelle Onorato, John A Bartlett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3R B Pollard, D Peterson, D Hardy, et al.
AIDS (London, England)|November 2, 2005
Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individualsHaydar Kuekrek, Tobias Schlingmann, Hernan Valdez, et al.
Pageof 65